{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:35:42Z","timestamp":1783528542257,"version":"3.55.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07887-x","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:14:44Z","timestamp":1766571284000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cellular stress, cell death, and extracellular vesicles: redefining the therapeutic landscape of rheumatoid arthritis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-2786","authenticated-orcid":false,"given":"Barathan","family":"Muttiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrul Abdul","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"1","key":"7887_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92150-1","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Gao X, Liu S, Wang Q, Wang Y, Hou S, Wang J, Zhang Y (2025) Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021. Sci Rep 15(1):10736. https:\/\/doi.org\/10.1038\/s41598-025-92150-1","journal-title":"Sci Rep"},{"key":"7887_CR2","doi-asserted-by":"publisher","first-page":"1547763","DOI":"10.3389\/fimmu.2025.1547763","volume":"16","author":"L Wei","year":"2025","unstructured":"Wei L, Chen X, Liu M (2025) Global, regional, and national burden and trends of rheumatoid arthritis among the elderly population: an analysis based on the 2021 Global Burden of Disease study. Front Immunol 16:1547763. https:\/\/doi.org\/10.3389\/fimmu.2025.1547763","journal-title":"Front Immunol"},{"key":"7887_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40364-025-00760-8","volume":"13","author":"Y Ma","year":"2025","unstructured":"Ma Y, Chen H, Lv W et al (2025) Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021. Biomark Res 13:47. https:\/\/doi.org\/10.1186\/s40364-025-00760-8","journal-title":"Biomark Res"},{"issue":"5","key":"7887_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3899\/jrheum.200367","volume":"48","author":"KB Almutairi","year":"2021","unstructured":"Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA (2021) The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol 48(5):669\u2013676. https:\/\/doi.org\/10.3899\/jrheum.200367","journal-title":"J Rheumatol"},{"issue":"4","key":"7887_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.31138\/mjr.301223.eaf","volume":"34","author":"AI Venetsanopoulou","year":"2023","unstructured":"Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA (2023) Epidemiology and risk factors for rheumatoid arthritis development. Mediterr J Rheumatol 34(4):404\u2013413. https:\/\/doi.org\/10.31138\/mjr.301223.eaf","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"7887_CR6","doi-asserted-by":"publisher","first-page":"010409","DOI":"10.7189\/jogh.05.010409","volume":"5","author":"I Rudan","year":"2015","unstructured":"Rudan I, Sidhu S, Papana A, Meng SJ, Xin-Wei Y, Wang W, Campbell-Page RM, Demaio AR, Nair H, Sridhar D, Theodoratou E, Dowman B, Adeloye D, Majeed A, Car J, Campbell H, Wang W, Chan KY (2015) Global Health Epidemiology Reference Group (GHERG). Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis. J Glob Health 5(1):010409. https:\/\/doi.org\/10.7189\/jogh.05.010409","journal-title":"J Glob Health"},{"issue":"6","key":"7887_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325127","volume":"20","author":"J Li","year":"2025","unstructured":"Li J, Li Z, Hao C, Chen X (2025) Global burden and regional disparities of rheumatoid arthritis among the working-age population: a comprehensive analysis from 1990 to 2021 with projections to 2040. PLoS ONE 20(6):e0325127. https:\/\/doi.org\/10.1371\/journal.pone.0325127","journal-title":"PLoS ONE"},{"issue":"11","key":"7887_CR8","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","volume":"78","author":"S Safiri","year":"2019","unstructured":"Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad A, Moradi-Lakeh M, Qorbani M, Collins G, Woolf AD, March L, Cross M (2019) Global, regional and national burden of rheumatoid arthritis 1990\u20132017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 78(11):1463\u20131471. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215920","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7887_CR9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.5114\/aoms\/183955","volume":"20","author":"M Zhang","year":"2024","unstructured":"Zhang M, Li M, Hu H, Li X, Tian M (2024) Global, regional, and national burdens of rheumatoid arthritis in young adults from 1990 to 2019. Arch Med Sci 20(4):1153\u20131162. https:\/\/doi.org\/10.5114\/aoms\/183955","journal-title":"Arch Med Sci"},{"issue":"11","key":"7887_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112857","volume":"10","author":"AF Radu","year":"2021","unstructured":"Radu AF, Bungau SG (2021) Management of rheumatoid arthritis: an overview. Cells 10(11):2857. https:\/\/doi.org\/10.3390\/cells10112857","journal-title":"Cells"},{"key":"7887_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1547763","volume":"16","author":"L Wei","year":"2025","unstructured":"Wei L, Chen X, Liu M (2025) Global, regional, and national burden and trends of rheumatoid arthritis among the elderly population: an analysis based on the 2021 Global Burden of Disease study. Front Immunol 16:1547763. https:\/\/doi.org\/10.3389\/fimmu.2025.1547763","journal-title":"Front Immunol"},{"issue":"1","key":"7887_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-03052-1","volume":"37","author":"S Cacciatore","year":"2025","unstructured":"Cacciatore S, Mao S, Nu\u00f1ez MV, Massaro C, Spadafora L, Bernardi M, Perone F, Sabouret P, Biondi-Zoccai G, Banach M, Calvani R, Tosato M, Marzetti E, Landi F (2025) Urban health inequities and healthy longevity: traditional and emerging risk factors across the cities and policy implications. Aging Clin Exp Res 37(1):143. https:\/\/doi.org\/10.1007\/s40520-025-03052-1","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"7887_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.5114\/aoms\/162629","volume":"19","author":"W Zou","year":"2023","unstructured":"Zou W, Fang Y, Xu D, Zhu Y (2023) Increasing global burden of rheumatoid arthritis: an epidemiological analysis from 1990 to 2019. Arch Med Sci\u202f: AMS 19(4):1037\u20131048. https:\/\/doi.org\/10.5114\/aoms\/162629","journal-title":"Arch Med Sci : AMS"},{"key":"7887_CR14","doi-asserted-by":"publisher","unstructured":"GBD 2021 Risk Factors Collaborators (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England), 403(10440), 2162\u20132203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4","DOI":"10.1016\/S0140-6736(24)00933-4"},{"issue":"5","key":"7887_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.55563\/clinexprheumatol\/166dsf","volume":"42","author":"E Molteni","year":"2024","unstructured":"Molteni E, Adinolfi A, Bondi V, Delvino P, Sakellariou G, Trentanni C, Ughi N, Pozzi MR, Scir\u00e8 CA (2024) Novel insights into the management of rheumatoid arthritis: one year in review 2024. Clin Exp Rheumatol 42(5):947\u2013960. https:\/\/doi.org\/10.55563\/clinexprheumatol\/166dsf","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"7887_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.102019","volume":"39","author":"C Cubberley","year":"2025","unstructured":"Cubberley C, Maharaj A (2025) Global RA treatment recommendations: an update from the various international societies. Best Pract Res Clin Rheumatol 39(1):102019. https:\/\/doi.org\/10.1016\/j.berh.2024.102019","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"7887_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","volume":"86","author":"B Friedman","year":"2019","unstructured":"Friedman B, Cronstein B (2019) Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine 86(3):301\u2013307. https:\/\/doi.org\/10.1016\/j.jbspin.2018.07.004","journal-title":"Joint Bone Spine"},{"key":"7887_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13075-024-03452-0","volume":"26","author":"T Dixit","year":"2024","unstructured":"Dixit T, Vaidya A, Ravindran S (2024) Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 26:216. https:\/\/doi.org\/10.1186\/s13075-024-03452-0","journal-title":"Arthritis Res Ther"},{"key":"7887_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15. https:\/\/doi.org\/10.1038\/s41413-018-0016-9","journal-title":"Bone Res"},{"issue":"3","key":"7887_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.509","volume":"5","author":"Y Gao","year":"2024","unstructured":"Gao Y, Zhang Y, Liu X (2024) Rheumatoid arthritis: pathogenesis and therapeutic advances. MedComm 5(3):e509. https:\/\/doi.org\/10.1002\/mco2.509","journal-title":"MedComm"},{"issue":"8","key":"7887_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40265-024-02059-8","volume":"84","author":"EG Favalli","year":"2024","unstructured":"Favalli EG, Maioli G, Caporali R (2024) Biologics or janus kinase inhibitors in rheumatoid arthritis patients who are insufficient responders to conventional anti-rheumatic drugs. Drugs 84(8):877\u2013894. https:\/\/doi.org\/10.1007\/s40265-024-02059-8","journal-title":"Drugs"},{"key":"7887_CR22","doi-asserted-by":"publisher","first-page":"113126","DOI":"10.1016\/j.biopha.2022.113126","volume":"151","author":"R Ben Mrid","year":"2022","unstructured":"Ben Mrid R, Bouchmaa N, Ainani H, El Fatimy R, Malka G, Mazini L (2022) Anti-rheumatoid drugs advancements: new insights into the molecular treatment of rheumatoid arthritis. Biomed Pharmacother = Biomedecine Pharmacotherapie 151:113126. https:\/\/doi.org\/10.1016\/j.biopha.2022.113126","journal-title":"Biomed Pharmacother = Biomedecine Pharmacotherapie"},{"issue":"12","key":"7887_CR23","doi-asserted-by":"publisher","first-page":"CD014897","DOI":"10.1002\/14651858.CD014897","volume":"2021","author":"EP Hepworth","year":"2021","unstructured":"Hepworth EP, Lee A, Pardo Pardo J, Aydin SZ, Tugwell P (2021) Short-term induction glucocorticoids and disease-modifying anti-rheumatic drugs (DMARD) therapy for rheumatoid arthritis. Cochrane Database Syst Rev 2021(12):CD014897. https:\/\/doi.org\/10.1002\/14651858.CD014897","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"7887_CR24","doi-asserted-by":"publisher","first-page":"991677","DOI":"10.3389\/fmed.2022.991677","volume":"29","author":"J Majnik","year":"2022","unstructured":"Majnik J, Cs\u00e1sz\u00e1r-Nagy N, B\u00f6cskei G, Bender T, Nagy G (2022) Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis. Front Med (Lausanne) 29(9):991677. https:\/\/doi.org\/10.3389\/fmed.2022.991677","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"7887_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00264-025-06441-3","volume":"49","author":"P Hernigou","year":"2025","unstructured":"Hernigou P (2025) Is synovectomy still of benefit today in total knee arthroplasty with rheumatoid arthritis? Int Orthop 49(3):641\u2013646. https:\/\/doi.org\/10.1007\/s00264-025-06441-3","journal-title":"Int Orthop"},{"issue":"7","key":"7887_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Mill\u00e1n I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA (2021) 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 73(7):924\u2013939. https:\/\/doi.org\/10.1002\/acr.24596","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"7887_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/mr\/roac046","volume":"33","author":"Y Kaneko","year":"2023","unstructured":"Kaneko Y, Sakurai M, Snijder R, Kokubo S, Kato D (2023) A retrospective, longitudinal study of rheumatoid arthritis treatment patterns with Janus kinase inhibitors and other disease-modifying antirheumatic drugs in Japan. Mod Rheumatol 33(3):448\u2013459. https:\/\/doi.org\/10.1093\/mr\/roac046","journal-title":"Mod Rheumatol"},{"key":"7887_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3057624","volume":"2018","author":"M Wang","year":"2018","unstructured":"Wang M, Yuan Q, Xie L (2018) Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem Cells Int 2018:3057624. https:\/\/doi.org\/10.1155\/2018\/3057624","journal-title":"Stem Cells Int"},{"issue":"4","key":"7887_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14712598.2022.2016695","volume":"22","author":"LL Bagno","year":"2022","unstructured":"Bagno LL, Salerno AG, Balkan W, Hare JM (2022) Mechanism of action of mesenchymal stem cells (MSCs): impact of delivery method. Expert Opin Biol Ther 22(4):449\u2013463. https:\/\/doi.org\/10.1080\/14712598.2022.2016695","journal-title":"Expert Opin Biol Ther"},{"key":"7887_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH (2018) Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther 9:63. https:\/\/doi.org\/10.1186\/s13287-018-0791-7","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"7887_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, Guo L, Zhang X, Zhou X, Xu X, Yan X, Wang Y, Zhang J, Xu A, Tse HF, Lian Q (2022) Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis 13(7):580. https:\/\/doi.org\/10.1038\/s41419-022-05034-x","journal-title":"Cell Death Dis"},{"key":"7887_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13287-025-04495-z","volume":"16","author":"YF Gao","year":"2025","unstructured":"Gao YF, Zhao N, Hu CH (2025) Harnessing mesenchymal stem\/stromal cells-based therapies for rheumatoid arthritis: mechanisms, clinical applications, and microenvironmental interactions. Stem Cell Res Ther 16:379. https:\/\/doi.org\/10.1186\/s13287-025-04495-z","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"7887_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J (2020) Immune modulation by mesenchymal stem cells. Cell Prolif 53(1):e12712. https:\/\/doi.org\/10.1111\/cpr.12712","journal-title":"Cell Prolif"},{"key":"7887_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104771","volume":"393","author":"S Dehnavi","year":"2023","unstructured":"Dehnavi S, Sadeghi M, Tavakol Afshari J, Mohammadi M (2023) Interactions of mesenchymal stromal\/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis. Cell Immunol 393:104771. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104771","journal-title":"Cell Immunol"},{"issue":"21","key":"7887_CR35","doi-asserted-by":"publisher","first-page":"13016","DOI":"10.3390\/ijms232113016","volume":"23","author":"SS Kuppa","year":"2022","unstructured":"Kuppa SS, Kim HK, Kang JY, Lee SC, Seon JK (2022) Role of mesenchymal stem cells and their paracrine mediators in macrophage polarization: an approach to reduce inflammation in osteoarthritis. Int J Mol Sci 23(21):13016. https:\/\/doi.org\/10.3390\/ijms232113016","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7887_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE (2013) Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13(4):392\u2013402. https:\/\/doi.org\/10.1016\/j.stem.2013.09.006","journal-title":"Cell Stem Cell"},{"issue":"3","key":"7887_CR37","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijms23031618","volume":"23","author":"DG Kwon","year":"2022","unstructured":"Kwon DG, Kim MK, Jeon YS, Nam YC, Park JS, Ryu DJ (2022) State of the art: the immunomodulatory role of MSCs for osteoarthritis. Int J Mol Sci 23(3):1618. https:\/\/doi.org\/10.3390\/ijms23031618","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7887_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/wound.2012.0420","volume":"2","author":"MN Knight","year":"2013","unstructured":"Knight MN, Hankenson KD (2013) Mesenchymal stem cells in bone regeneration. Adv Wound Care 2(6):306\u2013316. https:\/\/doi.org\/10.1089\/wound.2012.0420","journal-title":"Adv Wound Care"},{"issue":"24","key":"7887_CR39","doi-asserted-by":"publisher","first-page":"e2305116","DOI":"10.1002\/advs.202305116","volume":"11","author":"C Li","year":"2024","unstructured":"Li C, Sun Y, Xu W, Chang F, Wang Y, Ding J (2024) Mesenchymal stem cells-involved strategies for rheumatoid arthritis therapy. Adv Sci (Weinheim, Baden-Wurttemberg, Germany) 11(24):e2305116. https:\/\/doi.org\/10.1002\/advs.202305116","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"6","key":"7887_CR40","first-page":"203","volume":"6","author":"M Vohra","year":"2020","unstructured":"Vohra M, Sharma A, Bagga R, Arora SK (2020) Human umbilical cord-derived mesenchymal stem cells induce tissue repair and regeneration in collagen-induced arthritis in rats. J Clin Transl Res 6(6):203\u2013216","journal-title":"J Clin Transl Res"},{"issue":"1","key":"7887_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","volume":"23","author":"LT Wang","year":"2016","unstructured":"Wang LT, Ting CH, Yen ML, Liu KJ, Sytwu HK, Wu KK, Yen BL (2016) Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J Biomed Sci 23(1):76. https:\/\/doi.org\/10.1186\/s12929-016-0289-5","journal-title":"J Biomed Sci"},{"issue":"4","key":"7887_CR42","doi-asserted-by":"publisher","DOI":"10.21037\/atm-23-1951","volume":"12","author":"D Esquivel","year":"2024","unstructured":"Esquivel D, Mishra R, Srivastava A (2024) Potential use of stem cell therapies for treating osteoarthritis and rheumatoid arthritis. Ann Transl Med 12(4):72. https:\/\/doi.org\/10.21037\/atm-23-1951","journal-title":"Ann Transl Med"},{"key":"7887_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13287-023-03473-7","volume":"14","author":"M Babaahmadi","year":"2023","unstructured":"Babaahmadi M, Tayebi B, Gholipour NM et al (2023) Rheumatoid arthritis: the old issue, the new therapeutic approach. Stem Cell Res Ther 14:268. https:\/\/doi.org\/10.1186\/s13287-023-03473-7","journal-title":"Stem Cell Res Ther"},{"issue":"21","key":"7887_CR44","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.3390\/ijms222111592","volume":"22","author":"M Sarsenova","year":"2021","unstructured":"Sarsenova M, Issabekova A, Abisheva S, Rutskaya-Moroshan K, Ogay V, Saparov A (2021) Mesenchymal stem cell-based therapy for rheumatoid arthritis. Int J Mol Sci 22(21):11592. https:\/\/doi.org\/10.3390\/ijms222111592","journal-title":"Int J Mol Sci"},{"key":"7887_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-8722-5-19","volume":"5","author":"S Wang","year":"2012","unstructured":"Wang S, Qu X, Zhao RC (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:19. https:\/\/doi.org\/10.1186\/1756-8722-5-19","journal-title":"J Hematol Oncol"},{"issue":"1","key":"7887_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00266-6","volume":"43","author":"T Manzoor","year":"2023","unstructured":"Manzoor T, Saleem A, Farooq N, Dar LA, Nazir J, Saleem S, Ismail S, Gugjoo MB, Shiekh PA, Ahmad SM (2023) Extracellular vesicles derived from mesenchymal stem cells - a novel therapeutic tool in infectious diseases. Inflamm Regen 43(1):17. https:\/\/doi.org\/10.1186\/s41232-023-00266-6","journal-title":"Inflamm Regen"},{"issue":"6","key":"7887_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.52601\/bpr.2024.240005","volume":"10","author":"Z Lin","year":"2024","unstructured":"Lin Z, Cai W, Sun Y, Han B, Hu Y, He Z, Chen X (2024) Mechanism and application of mesenchymal stem cells and their secreting extracellular vesicles in regulating CD4+T cells in immune diseases. Biophys Rep 10(6):403\u2013415. https:\/\/doi.org\/10.52601\/bpr.2024.240005","journal-title":"Biophys Rep"},{"key":"7887_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01912","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Li R, Liu T, Yang L, Yin G, Xie Q (2020) Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol 11:1912. https:\/\/doi.org\/10.3389\/fimmu.2020.01912","journal-title":"Front Immunol"},{"issue":"20","key":"7887_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26209950","volume":"26","author":"F Machaj","year":"2025","unstructured":"Machaj F, Chmielewska-Jeznach M, Koryszewska-Bagi\u0144ska A, Malinowski D, Pawlik A, Ol\u0119dzka G (2025) MicroRNAs as biomarkers and therapeutic targets in rheumatoid arthritis. Int J Mol Sci 26(20):9950. https:\/\/doi.org\/10.3390\/ijms26209950","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7887_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11739-011-0517-7","volume":"6","author":"G Murdaca","year":"2011","unstructured":"Murdaca G, Colombo BM, Puppo F (2011) The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med 6(6):487\u2013495. https:\/\/doi.org\/10.1007\/s11739-011-0517-7","journal-title":"Intern Emerg Med"},{"issue":"8","key":"7887_CR51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/00002030-200105250-00004","volume":"15","author":"P Costa","year":"2001","unstructured":"Costa P, Rusconi S, Mavilio D, Fogli M, Murdaca G, Pende D, Mingari MC, Galli M, Moretta L, De Maria A (2001) Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. AIDS (London, England) 15(8):965\u2013974. https:\/\/doi.org\/10.1097\/00002030-200105250-00004","journal-title":"AIDS (London, England)"},{"key":"7887_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1196\/annals.1313.013","volume":"1050","author":"G Filaci","year":"2005","unstructured":"Filaci G, Rizzi M, Setti M, Fenoglio D, Fravega M, Basso M, Ansaldo G, Ceppa P, Borgonovo G, Murdaca G, Ferrera F, Picciotto A, Fiocca R, Torre G, Indiveri F (2005) Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci 1050:115\u2013123. https:\/\/doi.org\/10.1196\/annals.1313.013","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"7887_CR53","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","volume":"201","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wang H, Xia Y, Yan F, Lu Y (2018) Therapeutic potential of mesenchymal cell-derived miRNA-150\u20135p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol (Baltimore, Md.) 201(8):2472\u20132482. https:\/\/doi.org\/10.4049\/jimmunol.1800304","journal-title":"J Immunol (Baltimore, Md.)"},{"issue":"1","key":"7887_CR54","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s13287-020-01937-8","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q, Xu J (2020) Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Res Ther 11(1):424. https:\/\/doi.org\/10.1186\/s13287-020-01937-8","journal-title":"Stem Cell Res Ther"},{"key":"7887_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-025-01098-z","author":"Y Bai","year":"2025","unstructured":"Bai Y, Zhao J, Abtahi M, Liu X (2025) Therapeutic potential of miR-10a overexpressing mesenchymal stem cell-derived extracellular vesicles in modulating inflammation in collagen-induced arthritis. In Vitro Cell Dev Biol. https:\/\/doi.org\/10.1007\/s11626-025-01098-z","journal-title":"In Vitro Cell Dev Biol"},{"issue":"9","key":"7887_CR56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K (2020) Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci 41(9):653\u2013664. https:\/\/doi.org\/10.1016\/j.tips.2020.06.009","journal-title":"Trends Pharmacol Sci"},{"issue":"31","key":"7887_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043623","volume":"104","author":"T Wang","year":"2025","unstructured":"Wang T, Tang X, Luo W, Chen ZH, Xia Y, Zhou X, Shu Y, Lu CY, Su W, Chen Q, Shen Z, Zhou B, Luo Z (2025) Roles of extracellular vesicles in rheumatoid arthritis: a bibliometric analysis. Medicine 104(31):e43623. https:\/\/doi.org\/10.1097\/MD.0000000000043623","journal-title":"Medicine"},{"key":"7887_CR58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40364-019-0156-0","volume":"7","author":"P Lai","year":"2019","unstructured":"Lai P, Weng J, Guo L, Chen X, Du X (2019) Novel insights into MSC-EVs therapy for immune diseases. Biomark Res 7:6. https:\/\/doi.org\/10.1186\/s40364-019-0156-0","journal-title":"Biomark Res"},{"key":"7887_CR59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, Liao R, Li X et al (2025) Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Sig Transduct Target Ther 10:262. https:\/\/doi.org\/10.1038\/s41392-025-02313-9","journal-title":"Sig Transduct Target Ther"},{"issue":"1\u20132","key":"7887_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00109-022-02276-2","volume":"101","author":"Z Heydari","year":"2023","unstructured":"Heydari Z, Peshkova M, Gonen ZB, Coretchi I, Eken A, Yay AH, Dogan ME, Gokce N, Akalin H, Kosheleva N, Galea-Abdusa D, Ulinici M, Vorojbit V, Shpichka A, Groppa S, Vosough M, Todiras M, Butnaru D, Ozkul Y, Timashev P (2023) EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities. J Mol Med 101(1\u20132):51\u201363. https:\/\/doi.org\/10.1007\/s00109-022-02276-2","journal-title":"J Mol Med"},{"issue":"12","key":"7887_CR61","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/stcltm\/szac075","volume":"11","author":"MJ Alcaraz","year":"2022","unstructured":"Alcaraz MJ, Guill\u00e9n MI (2022) Cellular and molecular targets of extracellular vesicles from mesenchymal stem\/stromal cells in rheumatoid arthritis. Stem Cells Transl Med 11(12):1177\u20131185. https:\/\/doi.org\/10.1093\/stcltm\/szac075","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"7887_CR62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4252\/wjsc.v12.i8.879","volume":"12","author":"JH Wang","year":"2020","unstructured":"Wang JH, Liu XL, Sun JM, Yang JH, Xu DH, Yan SS (2020) Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: a systematic review. World J Stem Cells 12(8):879\u2013896. https:\/\/doi.org\/10.4252\/wjsc.v12.i8.879","journal-title":"World J Stem Cells"},{"issue":"1","key":"7887_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03768-2","volume":"23","author":"B Li","year":"2025","unstructured":"Li B, Wu W, Xu W, Qian H, Ji C (2025) Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application. J Nanobiotechnology 23(1):678. https:\/\/doi.org\/10.1186\/s12951-025-03768-2","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"7887_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04507-y","volume":"16","author":"S Gong","year":"2025","unstructured":"Gong S, Li N, Peng Q, Wang F, Du R, Zhang B, Wang J, Han L, Zhang Y, Ning Z, Tan S, Gu Y, Wu L (2025) A scalable platform for EPSC-induced MSC extracellular vesicles with therapeutic potential. Stem Cell Res Ther 16(1):426. https:\/\/doi.org\/10.1186\/s13287-025-04507-y","journal-title":"Stem Cell Res Ther"},{"key":"7887_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01577","volume":"9","author":"M Vomero","year":"2018","unstructured":"Vomero M, Barbati C, Colasanti T, Perricone C, Novelli L, Ceccarelli F, Spinelli FR, Di Franco M, Conti F, Valesini G, Alessandri C (2018) Autophagy and rheumatoid arthritis: current knowledges and future perspectives. Front Immunol 9:1577. https:\/\/doi.org\/10.3389\/fimmu.2018.01577","journal-title":"Front Immunol"},{"issue":"11","key":"7887_CR66","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/cells10113017","volume":"10","author":"AL Mueller","year":"2021","unstructured":"Mueller AL, Payandeh Z, Mohammadkhani N, Mubarak SMH, Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M (2021) Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies. Cells 10(11):3017. https:\/\/doi.org\/10.3390\/cells10113017","journal-title":"Cells"},{"key":"7887_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7623145","volume":"2017","author":"L Zhu","year":"2017","unstructured":"Zhu L, Wang H, Wu Y, He Z, Qin Y, Shen Q (2017) The autophagy level is increased in the synovial tissues of patients with active rheumatoid arthritis and is correlated with disease severity. Mediators Inflamm 2017:7623145. https:\/\/doi.org\/10.1155\/2017\/7623145","journal-title":"Mediators Inflamm"},{"key":"7887_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117734","volume":"254","author":"J Karami","year":"2020","unstructured":"Karami J, Masoumi M, Khorramdelazad H, Bashiri H, Darvishi P, Sereshki HA, Shekarabi M, Sahebkar A (2020) Role of autophagy in the pathogenesis of rheumatoid arthritis: latest evidence and therapeutic approaches. Life Sci 254:117734. https:\/\/doi.org\/10.1016\/j.lfs.2020.117734","journal-title":"Life Sci"},{"issue":"6","key":"7887_CR69","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.4049\/jimmunol.0803458","volume":"182","author":"VL Crotzer","year":"2009","unstructured":"Crotzer VL, Blum JS (2009) Autophagy and its role in MHC-mediated antigen presentation. J Immunol 182(6):3335\u20133341. https:\/\/doi.org\/10.4049\/jimmunol.0803458","journal-title":"J Immunol"},{"issue":"10","key":"7887_CR70","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/biom10101398","volume":"10","author":"A Montaseri","year":"2020","unstructured":"Montaseri A, Giampietri C, Rossi M, Riccioli A, Del Fattore A, Filippini A (2020) The role of autophagy in osteoclast differentiation and bone resorption function. Biomolecules 10(10):1398. https:\/\/doi.org\/10.3390\/biom10101398","journal-title":"Biomolecules"},{"key":"7887_CR71","doi-asserted-by":"publisher","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K, Cecconi F, Choi AMK, Choi ME, Chu CT, Codogno P, Colombo MI, Cuervo AM, Deretic V, Dikic I, Elazar Z, Eskelinen EL, Fimia GM, \u2026 Pietrocola F (2021) Autophagy in major human diseases. The EMBO journal, 40(19), e108863. https:\/\/doi.org\/10.15252\/embj.2021108863","DOI":"10.15252\/embj.2021108863"},{"issue":"11","key":"7887_CR72","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nri.2016.100","volume":"16","author":"K Cadwell","year":"2016","unstructured":"Cadwell K (2016) Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol 16(11):661\u2013675. https:\/\/doi.org\/10.1038\/nri.2016.100","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"7887_CR73","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3390\/cells11081359","volume":"11","author":"AI Celia","year":"2022","unstructured":"Celia AI, Colafrancesco S, Barbati C, Alessandri C, Conti F (2022) Autophagy in rheumatic diseases: role in the pathogenesis and therapeutic approaches. Cells 11(8):1359. https:\/\/doi.org\/10.3390\/cells11081359","journal-title":"Cells"},{"issue":"8","key":"7887_CR74","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/ijms22083903","volume":"22","author":"L Doblado","year":"2021","unstructured":"Doblado L, Lueck C, Rey C, Samhan-Arias AK, Prieto I, Stacchiotti A, Monsalve M (2021) Mitophagy in human diseases. Int J Mol Sci 22(8):3903. https:\/\/doi.org\/10.3390\/ijms22083903","journal-title":"Int J Mol Sci"},{"issue":"12","key":"7887_CR75","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1089\/ars.2019.8013","volume":"32","author":"L Liu","year":"2020","unstructured":"Liu L, Liao X, Wu H, Li Y, Zhu Y, Chen Q (2020) Mitophagy and its contribution to metabolic and aging-associated disorders. Antioxid Redox Signal 32(12):906\u2013927. https:\/\/doi.org\/10.1089\/ars.2019.8013","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"7887_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14138","volume":"54","author":"A Zimmermann","year":"2024","unstructured":"Zimmermann A, Madeo F, Diwan A, Sadoshima J, Sedej S, Kroemer G, Abdellatif M (2024) Metabolic control of mitophagy. Eur J Clin Invest 54(4):e14138. https:\/\/doi.org\/10.1111\/eci.14138","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"7887_CR77","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.3390\/ijms23105650","volume":"23","author":"JH Nam","year":"2022","unstructured":"Nam JH, Lee JH, Choi HJ, Choi SY, Noh KE, Jung NC, Song JY, Choi J, Seo HG, Jung SY, Lim DS (2022) TNF-\u03b1 induces mitophagy in rheumatoid arthritis synovial fibroblasts, and mitophagy inhibition alleviates synovitis in collagen antibody-induced arthritis. Int J Mol Sci 23(10):5650. https:\/\/doi.org\/10.3390\/ijms23105650","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7887_CR78","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/15548627.2018.1532259","volume":"15","author":"J Araya","year":"2019","unstructured":"Araya J, Tsubouchi K, Sato N, Ito S, Minagawa S, Hara H, Hosaka Y, Ichikawa A, Saito N, Kadota T, Yoshida M, Fujita Y, Utsumi H, Kobayashi K, Yanagisawa H, Hashimoto M, Wakui H, Ishikawa T, Numata T, Kaneko Y, Kuwano K (2019) PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. Autophagy 15(3):510\u2013526. https:\/\/doi.org\/10.1080\/15548627.2018.1532259","journal-title":"Autophagy"},{"issue":"4","key":"7887_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7150\/ijbs.3.242","volume":"3","author":"H Zhou","year":"2007","unstructured":"Zhou H, Falkenburger BH, Schulz JB, Tieu K, Xu Z, Xia XG (2007) Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci 3(4):242\u2013250. https:\/\/doi.org\/10.7150\/ijbs.3.242","journal-title":"Int J Biol Sci"},{"issue":"7","key":"7887_CR80","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/biomedicines13071708","volume":"13","author":"A Iaconis","year":"2025","unstructured":"Iaconis A, Molinari F, Fusco R, Di Paola R (2025) Mitochondria as a disease-relevant organelle in rheumatoid arthritis: a key breakout in fight against the disease. Biomedicines 13(7):1708. https:\/\/doi.org\/10.3390\/biomedicines13071708","journal-title":"Biomedicines"},{"issue":"10","key":"7887_CR81","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5483\/bmbrep.2016.49.10.115","volume":"49","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Yoon JH, Ryu JH (2016) Mitophagy: a balance regulator of NLRP3 inflammasome activation. BMB Rep 49(10):529\u2013535. https:\/\/doi.org\/10.5483\/bmbrep.2016.49.10.115","journal-title":"BMB Rep"},{"key":"7887_CR82","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X (2025) Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Sig Transduct Target Ther 10:190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4","journal-title":"Sig Transduct Target Ther"},{"key":"7887_CR83","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2147\/JIR.S398690","volume":"16","author":"G Wang","year":"2023","unstructured":"Wang G, Chen X, Shao Y, Xu B (2023) PINK1\/parkin-mediated mitochondrial autophagy participates in H2O2-induced abnormal proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. J Inflamm Res 16:1271\u20131282. https:\/\/doi.org\/10.2147\/JIR.S398690","journal-title":"J Inflamm Res"},{"key":"7887_CR84","doi-asserted-by":"publisher","first-page":"1260839","DOI":"10.3389\/fimmu.2023.1260839","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao H, Tang C, Wang M, Zhao H, Zhu Y (2023) Ferroptosis as an emerging target in rheumatoid arthritis. Front Immunol 14:1260839. https:\/\/doi.org\/10.3389\/fimmu.2023.1260839","journal-title":"Front Immunol"},{"key":"7887_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin Hl et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"key":"7887_CR86","doi-asserted-by":"publisher","first-page":"1269451","DOI":"10.3389\/fimmu.2023.1269451","volume":"14","author":"XD Zhang","year":"2023","unstructured":"Zhang XD, Liu ZY, Wang MS, Guo YX, Wang XK, Luo K, Huang S, Li RF (2023) Mechanisms and regulations of ferroptosis. Front Immunol 14:1269451. https:\/\/doi.org\/10.3389\/fimmu.2023.1269451","journal-title":"Front Immunol"},{"issue":"3","key":"7887_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W (2023) GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer 1878(3):188890. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188890","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7887_CR88","doi-asserted-by":"publisher","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA (2023) ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol 11:1226044. https:\/\/doi.org\/10.3389\/fcell.2023.1226044","journal-title":"Front Cell Dev Biol"},{"issue":"15","key":"7887_CR89","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.3390\/ijms25158212","volume":"25","author":"S Bieri","year":"2024","unstructured":"Bieri S, M\u00f6ller B, Amsler J (2024) Ferroptosis in arthritis: driver of the disease or therapeutic option? Int J Mol Sci 25(15):8212. https:\/\/doi.org\/10.3390\/ijms25158212","journal-title":"Int J Mol Sci"},{"key":"7887_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111913","volume":"132","author":"PR Gan","year":"2024","unstructured":"Gan PR, Wu H, Zhu YL, Shu Y, Wei Y (2024) Glycolysis, a driving force of rheumatoid arthritis. Int Immunopharmacol 132:111913. https:\/\/doi.org\/10.1016\/j.intimp.2024.111913","journal-title":"Int Immunopharmacol"},{"key":"7887_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930278","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Guo S, Schrodi SJ, He D (2022) Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: implication, prospects, and perspectives. Front Immunol 13:930278. https:\/\/doi.org\/10.3389\/fimmu.2022.930278","journal-title":"Front Immunol"},{"key":"7887_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110804","volume":"123","author":"A Wang","year":"2023","unstructured":"Wang A, Liu W, Jin Y, Wei B, Fan Y, Guo X, Gou X (2023) Identification of immunological characteristics and cuproptosis-related molecular clusters in rheumatoid arthritis. Int Immunopharmacol 123:110804. https:\/\/doi.org\/10.1016\/j.intimp.2023.110804","journal-title":"Int Immunopharmacol"},{"key":"7887_CR93","doi-asserted-by":"publisher","first-page":"1520400","DOI":"10.3389\/fmed.2025.1520400","volume":"12","author":"X Li","year":"2025","unstructured":"Li X, Zhang X, Liu T, Zhang G, Chen D, Lin S (2025) Identification of immune characteristic biomarkers and therapeutic targets in cuproptosis for rheumatoid arthritis by integrated bioinformatics analysis and single-cell RNA sequencing analysis. Front Med Lausanne 12:1520400. https:\/\/doi.org\/10.3389\/fmed.2025.1520400","journal-title":"Front Med Lausanne"},{"issue":"12","key":"7887_CR94","doi-asserted-by":"publisher","first-page":"09","DOI":"10.7860\/JCDR\/2015\/14851.7001","volume":"9","author":"M Chakraborty","year":"2015","unstructured":"Chakraborty M, Chutia H, Changkakati R (2015) Serum copper as a marker of disease activity in rheumatoid arthritis. J Clin Diagn Res: JCDR 9(12):09\u201311. https:\/\/doi.org\/10.7860\/JCDR\/2015\/14851.7001","journal-title":"J Clin Diagn Res: JCDR"},{"issue":"11","key":"7887_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3535","volume":"25","author":"H Hu","year":"2023","unstructured":"Hu H, Dou X, Hu X, Wang L, Ma Y, Liu J, Zhou X, Cao H, Liu X, Deng X, Li N (2023) Identification of a novel cuproptosis-related gene signature for rheumatoid arthritis-a prospective study. J Gene Med 25(11):e3535. https:\/\/doi.org\/10.1002\/jgm.3535","journal-title":"J Gene Med"},{"key":"7887_CR96","doi-asserted-by":"publisher","first-page":"1659541","DOI":"10.3389\/fimmu.2025.1659541","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, Liu J, Wan L, Wang F, Li Y (2025) Metabolic reprogramming: the central mechanism driving inflammatory polarization in rheumatoid arthritis and the regulatory role of traditional Chinese medicine. Front Immunol 16:1659541. https:\/\/doi.org\/10.3389\/fimmu.2025.1659541","journal-title":"Front Immunol"},{"issue":"5","key":"7887_CR97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","volume":"13","author":"CM Weyand","year":"2017","unstructured":"Weyand CM, Goronzy JJ (2017) Immunometabolism in early and late stages of rheumatoid arthritis. Nat Rev Rheumatol 13(5):291\u2013301. https:\/\/doi.org\/10.1038\/nrrheum.2017.49","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"7887_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451381","volume":"55","author":"\u00d3C Henry","year":"2025","unstructured":"Henry \u00d3C, O\u2019Neill LAJ (2025) Metabolic reprogramming in stromal and immune cells in rheumatoid arthritis and osteoarthritis: therapeutic possibilities. Eur J Immunol 55(4):e202451381. https:\/\/doi.org\/10.1002\/eji.202451381","journal-title":"Eur J Immunol"},{"issue":"1","key":"7887_CR99","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, Zhang C, Liu D, Zheng M, Gao J (2024) Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther 9(1):124. https:\/\/doi.org\/10.1038\/s41392-024-01839-8","journal-title":"Signal Transduct Target Ther"},{"key":"7887_CR100","doi-asserted-by":"publisher","first-page":"1250884","DOI":"10.3389\/fimmu.2024.1250884","volume":"15","author":"Z Hu","year":"2024","unstructured":"Hu Z, Li Y, Zhang L, Jiang Y, Long C, Yang Q, Yang M (2024) Metabolic changes in fibroblast-like synoviocytes in rheumatoid arthritis: state of the art review. Front Immunol 15:1250884. https:\/\/doi.org\/10.3389\/fimmu.2024.1250884","journal-title":"Front Immunol"},{"key":"7887_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.828191","volume":"13","author":"Y Qin","year":"2022","unstructured":"Qin Y, Gao C, Luo J (2022) Metabolism characteristics of Th17 and regulatory T cells in autoimmune diseases. Front Immunol 13:828191. https:\/\/doi.org\/10.3389\/fimmu.2022.828191","journal-title":"Front Immunol"},{"key":"7887_CR102","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3389\/fimmu.2017.01632","volume":"8","author":"L Sun","year":"2017","unstructured":"Sun L, Fu J, Zhou Y (2017) Metabolism controls the balance of Th17\/T-regulatory cells. Front Immunol 8:1632. https:\/\/doi.org\/10.3389\/fimmu.2017.01632","journal-title":"Front Immunol"},{"key":"7887_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107064","volume":"89","author":"M Masoumi","year":"2020","unstructured":"Masoumi M, Mehrabzadeh M, Mahmoudzehi S, Mousavi MJ, Jamalzehi S, Sahebkar A, Karami J (2020) Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: latest evidence and therapeutic approaches in rheumatoid arthritis. Int Immunopharmacol 89:107064. https:\/\/doi.org\/10.1016\/j.intimp.2020.107064","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"7887_CR104","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS (2020) Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 16(6):316\u2013333. https:\/\/doi.org\/10.1038\/s41584-020-0413-5","journal-title":"Nat Rev Rheumatol"},{"key":"7887_CR105","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3389\/fimmu.2019.01743","volume":"10","author":"PG de Oliveira","year":"2019","unstructured":"de Oliveira PG, Farinon M, Sanchez-Lopez E, Miyamoto S, Guma M (2019) Fibroblast-like synoviocytes glucose metabolism as a therapeutic target in rheumatoid arthritis. Front Immunol 10:1743. https:\/\/doi.org\/10.3389\/fimmu.2019.01743","journal-title":"Front Immunol"},{"key":"7887_CR106","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41584-023-01051-y","volume":"19","author":"J McHugh","year":"2023","unstructured":"McHugh J (2023) Dual inhibitor targets fibroblast metabolism in RA. Nat Rev Rheumatol 19:760. https:\/\/doi.org\/10.1038\/s41584-023-01051-y","journal-title":"Nat Rev Rheumatol"},{"key":"7887_CR107","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu CH, Lei M et al (2024) Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Sig Transduct Target Ther 9:268. https:\/\/doi.org\/10.1038\/s41392-024-01954-6","journal-title":"Sig Transduct Target Ther"},{"key":"7887_CR108","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","volume":"11","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhang H, Miao C (2025) Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives. Cell Death Discov 11:123. https:\/\/doi.org\/10.1038\/s41420-025-02403-1","journal-title":"Cell Death Discov"},{"issue":"3","key":"7887_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.162","volume":"3","author":"J Huang","year":"2022","unstructured":"Huang J, Hong W, Wan M, Zheng L (2022) Molecular mechanisms and therapeutic target of NETosis in diseases. MedComm 3(3):e162. https:\/\/doi.org\/10.1002\/mco2.162","journal-title":"MedComm"},{"issue":"21","key":"7887_CR110","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.3390\/ijms242115805","volume":"24","author":"MM Islam","year":"2023","unstructured":"Islam MM, Takeyama N (2023) Role of neutrophil extracellular traps in health and disease pathophysiology: recent insights and advances. Int J Mol Sci 24(21):15805. https:\/\/doi.org\/10.3390\/ijms242115805","journal-title":"Int J Mol Sci"},{"key":"7887_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578129","volume":"11","author":"W Song","year":"2021","unstructured":"Song W, Ye J, Pan N, Tan C, Herrmann M (2021) Neutrophil extracellular traps tied to rheumatoid arthritis: points to ponder. Front Immunol 11:578129. https:\/\/doi.org\/10.3389\/fimmu.2020.578129","journal-title":"Front Immunol"},{"key":"7887_CR112","doi-asserted-by":"publisher","first-page":"1438272","DOI":"10.3389\/fimmu.2024.1438272","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cao Y, Xiao J, Hong Y, Zhu Y (2024) The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis. Front Immunol 15:1438272. https:\/\/doi.org\/10.3389\/fimmu.2024.1438272","journal-title":"Front Immunol"},{"issue":"3","key":"7887_CR113","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003104","volume":"9","author":"D Melbouci","year":"2023","unstructured":"Melbouci D, Haidar Ahmad A, Decker P (2023) Neutrophil extracellular traps (NET): not only antimicrobial but also modulators of innate and adaptive immunities in inflammatory autoimmune diseases. RMD Open 9(3):e003104. https:\/\/doi.org\/10.1136\/rmdopen-2023-003104","journal-title":"RMD Open"},{"key":"7887_CR114","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkz001","volume":"8","author":"Y Yu","year":"2020","unstructured":"Yu Y, Sun B (2020) Autophagy-mediated regulation of neutrophils and clinical applications. Burns Trauma 8:tkz001. https:\/\/doi.org\/10.1093\/burnst\/tkz001","journal-title":"Burns Trauma"},{"key":"7887_CR115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10020-023-00717-3","volume":"29","author":"W Ren","year":"2023","unstructured":"Ren W, Zhao L, Sun Y et al (2023) HMGB1 and toll-like receptors: potential therapeutic targets in autoimmune diseases. Mol Med 29:117. https:\/\/doi.org\/10.1186\/s10020-023-00717-3","journal-title":"Mol Med"},{"issue":"5","key":"7887_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107602","volume":"31","author":"TD Tsourouktsoglou","year":"2020","unstructured":"Tsourouktsoglou TD, Warnatsch A, Ioannou M, Hoving D, Wang Q, Papayannopoulos V (2020) Histones, DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4. Cell Rep 31(5):107602. https:\/\/doi.org\/10.1016\/j.celrep.2020.107602","journal-title":"Cell Rep"},{"key":"7887_CR117","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-025-00670-3","volume":"14","author":"F Gao","year":"2025","unstructured":"Gao F, Peng H, Gou R et al (2025) Exploring neutrophil extracellular traps: mechanisms of immune regulation and future therapeutic potential. Exp Hematol Oncol 14:80. https:\/\/doi.org\/10.1186\/s40164-025-00670-3","journal-title":"Exp Hematol Oncol"},{"issue":"9","key":"7887_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102350","volume":"18","author":"G Murdaca","year":"2019","unstructured":"Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S (2019) Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications. Autoimmun Rev 18(9):102350. https:\/\/doi.org\/10.1016\/j.autrev.2019.102350","journal-title":"Autoimmun Rev"},{"issue":"11","key":"7887_CR119","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/biom11111624","volume":"11","author":"T Ao","year":"2021","unstructured":"Ao T, Kikuta J, Ishii M (2021) The effects of vitamin D on immune system and inflammatory diseases. Biomolecules 11(11):1624. https:\/\/doi.org\/10.3390\/biom11111624","journal-title":"Biomolecules"},{"key":"7887_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105663","volume":"200","author":"HMA Fakhoury","year":"2020","unstructured":"Fakhoury HMA, Kvietys PR, AlKattan W, Anouti FA, Elahi MA, Karras SN, Grant WB (2020) Vitamin D and intestinal homeostasis: barrier, microbiota, and immune modulation. J Steroid Biochem Mol Biol 200:105663. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105663","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"7887_CR121","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"issue":"1","key":"7887_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-025-00514-y","volume":"22","author":"H Ullah","year":"2025","unstructured":"Ullah H (2025) Gut-vitamin D interplay: key to mitigating immunosenescence and promoting healthy ageing. Immunity Ageing 22(1):20. https:\/\/doi.org\/10.1186\/s12979-025-00514-y","journal-title":"Immunity Ageing"},{"issue":"7","key":"7887_CR123","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.3390\/ijms26073148","volume":"26","author":"B Ma","year":"2025","unstructured":"Ma B, Barathan M, Ng MH, Law JX (2025) Oxidative stress, gut microbiota, and extracellular vesicles: interconnected pathways and therapeutic potentials. Int J Mol Sci 26(7):3148. https:\/\/doi.org\/10.3390\/ijms26073148","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7887_CR124","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1267\/ahc.20011","volume":"53","author":"NS Akimbekov","year":"2020","unstructured":"Akimbekov NS, Digel I, Sherelkhan DK, Lutfor AB, Razzaque MS (2020) Vitamin D and the host-gut microbiome: a brief overview. Acta Histochem Cytochem 53(3):33\u201342. https:\/\/doi.org\/10.1267\/ahc.20011","journal-title":"Acta Histochem Cytochem"},{"issue":"1","key":"7887_CR125","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","volume":"16","author":"Y Xu","year":"2020","unstructured":"Xu Y, Shen J, Ran Z (2020) Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy 16(1):3\u201317. https:\/\/doi.org\/10.1080\/15548627.2019.1603547","journal-title":"Autophagy"},{"issue":"Suppl 1","key":"7887_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/1478-6354-13-S1-S3","volume":"13","author":"FC Breedveld","year":"2011","unstructured":"Breedveld FC, Combe B (2011) Understanding emerging treatment paradigms in rheumatoid arthritis. Arthritis Res Ther 13(Suppl 1):S3. https:\/\/doi.org\/10.1186\/1478-6354-13-S1-S3","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"7887_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/00045632241285843","volume":"62","author":"D Sahin","year":"2025","unstructured":"Sahin D, Di Matteo A, Emery P (2025) Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: a comprehensive review. Ann Clin Biochem 62(1):3\u201321. https:\/\/doi.org\/10.1177\/00045632241285843","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"7887_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29849","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Ding S, Zhang P, Yan J, Yu X, Wang X, Zhan H, Wang Z (2024) Revealing the impact of autophagy-related genes in rheumatoid arthritis: insights from bioinformatics. Heliyon 10(9):e29849. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29849","journal-title":"Heliyon"},{"key":"7887_CR129","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s43166-023-00203-y","volume":"50","author":"SA Sarhan","year":"2023","unstructured":"Sarhan SA, Saad Hassan AA, Said NM et al (2023) The role of the Beclin-1: a gene related to autophagy in rheumatoid arthritis. Egypt Rheumatol Rehabil 50:34. https:\/\/doi.org\/10.1186\/s43166-023-00203-y","journal-title":"Egypt Rheumatol Rehabil"},{"key":"7887_CR130","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3389\/fimmu.2018.01577","volume":"9","author":"M Vomero","year":"2018","unstructured":"Vomero M, Barbati C, Colasanti T, Perricone C, Novelli L, Ceccarelli F, Spinelli FR, Di Franco M, Conti F, Valesini G, Alessandri C (2018) Autophagy and rheumatoid arthritis: current knowledges and future perspectives. Front Immunol 9:1577. https:\/\/doi.org\/10.3389\/fimmu.2018.01577","journal-title":"Front Immunol"},{"key":"7887_CR131","doi-asserted-by":"publisher","first-page":"1017650","DOI":"10.3389\/fmed.2022.1017650","volume":"9","author":"L Cui","year":"2022","unstructured":"Cui L, Weiyao J, Chenghong S, Limei L, Xinghua Z, Bo Y, Xiaozheng D, Haidong W (2022) Rheumatoid arthritis and mitochondrial homeostasis: the crossroads of metabolism and immunity. Front Med 9:1017650. https:\/\/doi.org\/10.3389\/fmed.2022.1017650","journal-title":"Front Med"},{"issue":"21","key":"7887_CR132","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.3390\/ijms262110449","volume":"26","author":"Z He","year":"2025","unstructured":"He Z, Liu B, Xian Z, Gong A, Jia X (2025) Ferroptosis in autoimmune diseases: research advances and therapeutic strategies. Int J Mol Sci 26(21):10449. https:\/\/doi.org\/10.3390\/ijms262110449","journal-title":"Int J Mol Sci"},{"key":"7887_CR133","doi-asserted-by":"publisher","first-page":"1204926","DOI":"10.3389\/fendo.2023.1204926","volume":"14","author":"M Jiang","year":"2023","unstructured":"Jiang M, Liu K, Lu S, Qiu Y, Zou X, Zhang K, Chen C, Jike Y, Xie M, Dai Y, Bo Z (2023) Verification of cuproptosis-related diagnostic model associated with immune infiltration in rheumatoid arthritis. Front Endocrinol 14:1204926. https:\/\/doi.org\/10.3389\/fendo.2023.1204926","journal-title":"Front Endocrinol"},{"issue":"2","key":"7887_CR134","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/MS9.0000000000002890","volume":"87","author":"L Shakeel","year":"2025","unstructured":"Shakeel L, Shaukat A, Khaliq N, Kashif A, Mujeeb A, Adnan Z, Taj J, Akilimali A (2025) Rheumatoid arthritis: a comprehensive overview of genetic markers, emerging therapies, and personalized medicine. Ann Med Surg 87(2):696\u2013710. https:\/\/doi.org\/10.1097\/MS9.0000000000002890","journal-title":"Ann Med Surg"},{"issue":"12","key":"7887_CR135","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.3390\/ijms26125766","volume":"26","author":"TO Klyucherev","year":"2025","unstructured":"Klyucherev TO, Peshkova MA, Yurkanova MD, Kosheleva NV, Svistunov AA, Liang XJ, Timashev PS (2025) Advances in regenerative therapies for inflammatory arthritis: exploring the potential of mesenchymal stem cells and extracellular vesicles. Int J Mol Sci 26(12):5766. https:\/\/doi.org\/10.3390\/ijms26125766","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7887_CR136","doi-asserted-by":"publisher","first-page":"313","DOI":"10.32592\/ARI.2025.80.2.313","volume":"80","author":"H Amirhossein","year":"2025","unstructured":"Amirhossein H, Arash A, Aida N, Asadollah A, Hussein AG (2025) Immunomodulatory functions of mesenchymal stem cells in tissue engineering. Arch Razi Inst 80(2):313\u2013324. https:\/\/doi.org\/10.32592\/ARI.2025.80.2.313","journal-title":"Arch Razi Inst"},{"issue":"11","key":"7887_CR137","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.3390\/ijms22115487","volume":"22","author":"HS Hwang","year":"2021","unstructured":"Hwang HS, Kim H, Han G, Lee JW, Kim K, Kwon IC, Yang Y, Kim SH (2021) Extracellular vesicles as potential therapeutics for inflammatory diseases. Int J Mol Sci 22(11):5487. https:\/\/doi.org\/10.3390\/ijms22115487","journal-title":"Int J Mol Sci"},{"key":"7887_CR138","doi-asserted-by":"publisher","first-page":"1503830","DOI":"10.3389\/fcvm.2024.1503830","volume":"11","author":"E Fu","year":"2024","unstructured":"Fu E, Pan K, Li Z (2024) Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease. Front Cardiovasc Med 11:1503830. https:\/\/doi.org\/10.3389\/fcvm.2024.1503830","journal-title":"Front Cardiovasc Med"},{"key":"7887_CR139","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12951-023-02081-0","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu Q, Li D, Pan X et al (2023) Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnol 21:334. https:\/\/doi.org\/10.1186\/s12951-023-02081-0","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"7887_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/biom9100530","volume":"9","author":"S Tavakol","year":"2019","unstructured":"Tavakol S, Ashrafizadeh M, Deng S, Azarian M, Abdoli A, Motavaf M, Poormoghadam D, Khanbabaei H, Afshar EG, Mandegary A, Pardakhty A, Yap CT, Mohammadinejad R, Kumar AP (2019) Autophagy modulators: mechanistic aspects and drug delivery systems. Biomolecules 9(10):530. https:\/\/doi.org\/10.3390\/biom9100530","journal-title":"Biomolecules"},{"issue":"1","key":"7887_CR141","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14656566.2023.2297798","volume":"25","author":"AI Venetsanopoulou","year":"2024","unstructured":"Venetsanopoulou AI, Voulgari PV, Drosos AA (2024) Advances in non-biological drugs for the treatment of rheumatoid arthritis. Expert Opin Pharmacother 25(1):45\u201353. https:\/\/doi.org\/10.1080\/14656566.2023.2297798","journal-title":"Expert Opin Pharmacother"},{"key":"7887_CR142","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221100294","volume":"14","author":"YJ Li","year":"2022","unstructured":"Li YJ, Chen Z (2022) Cell-based therapies for rheumatoid arthritis: opportunities and challenges. Ther Adv Musculoskelet Dis 14:1759720X221100294. https:\/\/doi.org\/10.1177\/1759720X221100294","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"11","key":"7887_CR143","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/cells13110915","volume":"13","author":"E Bakinowska","year":"2024","unstructured":"Bakinowska E, Bratborska AW, Kie\u0142bowski K, \u0106mil M, Biniek WJ, Pawlik A (2024) The role of mesenchymal stromal cells in the treatment of rheumatoid arthritis. Cells 13(11):915. https:\/\/doi.org\/10.3390\/cells13110915","journal-title":"Cells"},{"key":"7887_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107537","volume":"210","author":"GD Kalliolias","year":"2024","unstructured":"Kalliolias GD, Papavassiliou AG (2024) Targeting hypoxia inducible factor-1 alpha in rheumatoid arthritis: rationale, opportunities and challenges. Pharmacol Res 210:107537. https:\/\/doi.org\/10.1016\/j.phrs.2024.107537","journal-title":"Pharmacol Res"},{"key":"7887_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00184","volume":"7","author":"S Hua","year":"2016","unstructured":"Hua S, Dias TH (2016) Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis. Front Pharmacol 7:184. https:\/\/doi.org\/10.3389\/fphar.2016.00184","journal-title":"Front Pharmacol"},{"key":"7887_CR146","doi-asserted-by":"publisher","first-page":"154332","DOI":"10.1016\/j.prp.2023.154332","volume":"242","author":"X Yang","year":"2023","unstructured":"Yang X, Xia H, Liu C, Wu Y, Liu X, Cheng Y, Wang Y, Xia Y, Yue Y, Cheng X, Jia R (2023) The novel delivery-exosome application for diagnosis and treatment of rheumatoid arthritis. Pathol Res Pract 242:154332. https:\/\/doi.org\/10.1016\/j.prp.2023.154332","journal-title":"Pathol Res Pract"},{"issue":"7","key":"7887_CR147","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/1389557523666230913105803","volume":"24","author":"A Garhwal","year":"2024","unstructured":"Garhwal A, Kendya P, Soni S, Kori S, Soni V, Kashaw SK (2024) Drug delivery system approaches for rheumatoid arthritis treatment: a review. Mini Rev Med Chem 24(7):704\u2013720. https:\/\/doi.org\/10.2174\/1389557523666230913105803","journal-title":"Mini Rev Med Chem"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07887-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:42:09Z","timestamp":1769679729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07887-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7887"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07887-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (including individual details, images, or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}